SynopsisDiabetes mellitus is the main disease of Glycogen Metabolism Disease. The global Drugs for Glycogen Metabolism Disease market was valued at US$ 54230 million in 2023 and is anticipated to reach US$ 112580 million by 2030, witnessing a CAGR of 11.0% durin.....
SynopsisSwine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 p.....
SynopsisThe global Biodegradable Collagen Implant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to the data of the International Society of Aesthet.....
SynopsisThe global Emergency Patient Monitor market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Emergency Patient Monitor in various end use industries. The exp.....
SynopsisAsthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms inclu.....
SynopsisThe global Fetal Monitoring Analysis market was valued at US$ 2984 million in 2023 and is anticipated to reach US$ 4270.6 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030. North American market for Fetal Monitoring Analysis.....
SynopsisThe global High Intensity Focused Ultrasound Devices market was valued at US$ 325.4 million in 2023 and is anticipated to reach US$ 752.9 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030. North American market for High Int.....
SynopsisJevtana is a brand name for cabazitaxel, a chemotherapy medication used in the treatment of advanced prostate cancer that has become resistant to standard hormone therapy. Jevtana works by disrupting the growth and division of cancer cells. It is administered .....
SynopsisThe global Cholangiocarcinoma Pipeline market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, gr.....
SynopsisAlteplase, also known as tissue plasminogen activator (tPA), is a thrombolytic drug used to break down blood clots in various medical conditions, including heart attacks, strokes, and pulmonary embolisms. It works by activating the body's natural clot-dissolvi.....
